Search

Filters

Clear Filters
8:15 AM - 8:20 AM ET

1231 - Clinical Implementation of Body Surface Monitoring Based on Cone Beam CT for Adaptive Pediatric Proton Therapy
Speaker: Ates, Ozgur, PhD - St. Jude Children's Research Hospital, Memphis, TN
8:20 AM - 8:25 AM ET

1232 - A Novel Split-Field and Switching Breath-Hold Strategy for Maximal Heart Sparing in Left-Sided Postmastectomy Radiotherapy
Speaker: Li, Wenxiang, MS - The First affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang
8:25 AM - 8:30 AM ET

1233 - Predictive Motion Management Using Surface Electromyography (sEMG)
Speaker: Ashraf, Muhammad Ramish, PhD - Stanford Radiation Oncology, Palo Alto, CA
8:30 AM - 8:35 AM ET

1234 - Dosimetric Characterization of Biology-Guided Radiotherapy (BGRT) Toward Sub-Centimeter PET-Avid Lesions
Speaker: Groll, Andrew, PhD - Reflexion Medical, Inc. , Hayward, CA
9:20 AM - 9:25 AM ET

1235 - Hypo-Slow Radiotherapy Combined with Capecitabine in Very Elderly Patients (=78 Years) with Locally Advanced Head and Neck Cancer: A Prospective Exploratory Study
Speaker: Zhang, Shichuan, MD, PhD - Sichuan Cancer Hospital and Institute, ???, ???
9:25 AM - 9:30 AM ET

1236 - Split-Course Hypofractionated Radiotherapy in Elderly Patients with Head and Neck Squamous Cell Carcinoma: A Single-Center Prospective Phase II study
Speaker: Yang, Jia-Xuan, MS - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
9:30 AM - 9:35 AM ET

1237 - Somatic Genetic Variants as Predictors for Radiation-Induced Short and Long-Term Toxicity in Head and Neck Cancers
Speaker: Thompson, Austin, MD - University of Maryland Medical Center, Baltimore, MD
9:35 AM - 9:40 AM ET

1238 - Genetic Signatures Predicting Toxicity and Overall Survival in Head and Neck Squamous Cell Carcinoma (HNSCC) Patients in RTOG 0522 Treated with Radiation and Cisplatin
Speaker: Weidhaas, Joanne, MD, PhD - UCLA Radiation Oncology, Los Angeles, CA
9:40 AM - 9:45 AM ET

1239 - Stereotactic Ablative Radiotherapy (SABR) for Early Stage Glottic Cancer: A Multi-Institutional Pooled Analysis of Long-Term Efficacy, Toxicity and Voice Outcomes
Speaker: Young, Sympascho, MD, BS - UT Southwestern Medical Center, Dallas, TX
3:30 PM - 3:40 PM ET

124 - Biology-Guided Radiotherapy In Pan-HPV Head and Neck Cancer Using Genomic-Adjusted Radiation Dose
Speaker: Bergman, Drew, MD - Memorial Sloan Kettering Cancer Center, New York, NY
9:45 AM - 9:50 AM ET

1240 - Prospective Evaluation of Daily Online Adaptive Radiotherapy with 1mm PTV Margins in High Risk HPV Negative Head and Neck Cancer
Speaker: Bajwa, Harjot, MD - American Oncology Institute, Hyderabad
9:20 AM - 9:25 AM ET

1241 - Transcriptional and Non-Transcriptional Regulation of Radiotherapy Response by LUC7L3
Speaker: Xu, Rongli, MS - Department of Radiation Oncology Cancer Institute & Hospital, Chinese Academy of Medical Science, Beijing, Beijing